These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5316292)

  • 1. Ristocetin--a new tool in the investigation of platelet aggregation.
    Howard MA; Firkin BG
    Thromb Diath Haemorrh; 1971 Oct; 26(2):362-9. PubMed ID: 5316292
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
    Girolami A; Fabris F; Marco L; Peruffo R
    Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet function in congenital hemorrhagic diathesis (author's transl)].
    Izuchi Y; Deguchi K
    Rinsho Ketsueki; 1975 Apr; 16(4):415-22. PubMed ID: 1079885
    [No Abstract]   [Full Text] [Related]  

  • 4. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis.
    Caen JP; Levy-Toledano S
    Nat New Biol; 1973 Aug; 244(135):159-60. PubMed ID: 4541893
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Oct; 31(4):219-26. PubMed ID: 1080679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willebrand factor: immunological and biological study.
    Meyer D; Dreyfus MD; Larrieu MJ
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:66-71. PubMed ID: 4202741
    [No Abstract]   [Full Text] [Related]  

  • 10. [Willebrand's disease and platelet adhesiveness in the presence of ristocetine].
    Alexander P; Streiff F; Stoltz JF; Andre E
    Blut; 1975 Aug; 31(2):87-94. PubMed ID: 1080678
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Feb; 30(2):87-100. PubMed ID: 1111662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Inhibition of ristocetin-induced platelet aggregation by haemaccel.
    Stibbe J; Kirby EP
    Br Med J; 1975 Jun; 2(5973):750-1. PubMed ID: 1079739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet anomaly in an eosinophilic myelophroliferative syndrome].
    Wautier JL; Dupuy E; Michel H; Caen JP
    Nouv Presse Med; 1976 Mar; 5(11):704-6. PubMed ID: 1083506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.
    Howard MA; Hutton RA; Hardisty RM
    Br Med J; 1973 Jun; 2(5866):586-8. PubMed ID: 4541347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 16. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement of thrombocyte adhesion in children (author's transl)].
    Suschke J; Stehr K; Jacobi E; Jurzik ML; Krejci K
    Klin Padiatr; 1973 Jul; 185(4):287-96. PubMed ID: 4542896
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: 8-related antigen and von Willebrand factor.
    Firkin B; Koutts J
    Lancet; 1974 Apr; 1(7861):803-4. PubMed ID: 4132731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of platelet adhesiveness using a modified form of the Hellem II method with special reference to Von Willebrand-Jürgens syndrome].
    Niessner H
    Thromb Diath Haemorrh; 1972 Jul; 27(3):434-51. PubMed ID: 4541210
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Relation of von Willebrand factor to bleeding time.
    Weiss HJ
    N Engl J Med; 1974 Aug; 291(8):420. PubMed ID: 4546558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.